These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6346687)

  • 21. Effect of pregnancy on protection of mice immunized by Japanese encephalitis virus & its experimental inactivated vaccine.
    Soni GR
    Indian J Med Res; 1994 Aug; 100():57-8. PubMed ID: 7927555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Concentrated purified vaccine against tick-borne encephalitis prepared by means of zonal ultracentrifugation. Development of the preparation].
    El'bert LB; Gagarina AV; Khanina MK; Krutianskaia GL; Grachev VP
    Vopr Virusol; 1980; (3):341-5. PubMed ID: 7434727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An efficient method for production of purified inactivated Japanese encephalitis vaccine from mouse brains.
    Gupta RK; Misra CN; Gupta VK; Saxena SN
    Vaccine; 1991 Dec; 9(12):865-7. PubMed ID: 1811372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of the optimal dose of a cultured inactivated vaccine for preventing Japanese encephalitis].
    Grachev VP; Sumarokov AA; Kharazian EG; Shkol'nik RIa; Karinskaia GA
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):98-103. PubMed ID: 6322486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigenic analysis of Japanese encephalitis virus by using monoclonal antibodies.
    Kobayashi Y; Hasegawa H; Oyama T; Tamai T; Kusaba T
    Infect Immun; 1984 Apr; 44(1):117-23. PubMed ID: 6200438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Japanese encephalitis vaccines: moving away from the mouse brain.
    Zanin MP; Webster DE; Martin JL; Wesselingh SL
    Expert Rev Vaccines; 2003 Jun; 2(3):407-16. PubMed ID: 12903806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimeric classical swine fever (CSF)-Japanese encephalitis (JE) viral replicon as a non-transmissible vaccine candidate against CSF and JE infections.
    Yang Z; Wu R; Li RW; Li L; Xiong Z; Zhao H; Guo D; Pan Z
    Virus Res; 2012 Apr; 165(1):61-70. PubMed ID: 22285514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
    J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
    Yang SE; Pan MJ; Tseng HF; Liau MY
    Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzyme-linked immunosorbent assay for detection of serum antibody in children vaccinated with Japanese encephalitis vaccine.
    Okamoto Y; Okuno Y; Yamada A; Baba K; Yabuuchi H
    Biken J; 1986 Dec; 29(3-4):57-62. PubMed ID: 3619879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Japanese encephalitis vaccines: alternatives to production in mouse brain.
    Halstead SB; Thomas SJ
    Expert Rev Vaccines; 2011 Mar; 10(3):355-64. PubMed ID: 21434803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice.
    Cao JX; Ni H; Wills MR; Campbell GA; Sil BK; Ryman KD; Kitchen I; Barrett AD
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2757-64. PubMed ID: 7595383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants.
    Poland JD; Cropp CB; Craven RB; Monath TP
    J Infect Dis; 1990 May; 161(5):878-82. PubMed ID: 2324539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on immune response of attenuated Japanese encephalitis vaccine virus strain].
    Chen BQ; Tignor CH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Dec; 5(6):378-81. PubMed ID: 6233022
    [No Abstract]   [Full Text] [Related]  

  • 35. [Reactogenicity and immunological effectiveness of a concentrated, purified vaccine against tick-borne encephalitis].
    Vorob'eva MS; El'bert LB; Grachev VP; Lelikov VL; Pervikov IuV
    Vopr Virusol; 1983; 28(5):622-6. PubMed ID: 6659477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic characterization of nine wild-type Taiwanese isolates of Japanese encephalitis virus as compared with two vaccine strains.
    Wu SC; Lian WC; Hsu LC; Wu YC; Liau MY
    Virus Res; 1998 May; 55(1):83-91. PubMed ID: 9712514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of in vitro correlate of cell mediated immunity following Japanese encephalitis inactivated vaccine among laboratory personnel.
    Kelkar SD; Rodrigues FM; Banerjee K
    Indian J Med Res; 1986 Jan; 83():104-7. PubMed ID: 3699863
    [No Abstract]   [Full Text] [Related]  

  • 38. [Design of inactivated polyvalent antiherpes vaccines].
    Andonov P; Dundarov S; Bakalov B
    Vopr Virusol; 1979; (6):665-71. PubMed ID: 230648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of effectiveness of mouse brain inactivated Japanese encephalitis vaccine produced in India.
    Gowal D; Tahlan AK
    Indian J Med Res; 1995 Dec; 102():267-71. PubMed ID: 8557319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune status of volunteers one year after administration of Japanese encephalitis vaccine produced in India.
    Saxena SN; Bhau LN; Singh G; Gowal D; Sood YK; Misra CN; Das BK
    Indian J Med Res; 1989 Nov; 89():362-7. PubMed ID: 2559892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.